vs
Akso Health Group（AHG）与携程集团（TCOM）财务数据对比。点击上方公司名可切换其他公司
携程集团的季度营收约是Akso Health Group的43.5倍（$304.6M vs $7.0M）。携程集团净利率更高（27.8% vs -18.6%，领先46.4%）
阿克索健康集团是一家跨国医疗健康企业，专注于仿制药、非处方健康产品及医疗器械的研发、生产与分销，核心市场覆盖中国、东南亚及北美地区，业务范畴包含药品制造、医疗供应链及社区医疗服务板块。
携程集团是总部位于中国上海的跨国旅行服务企业，为全球最大的在线旅行服务提供商，业务覆盖机票预订、酒店预订、度假产品、商旅管理等领域，面向全球用户提供一站式旅行综合服务。
AHG vs TCOM — 直观对比
营收规模更大
TCOM
是对方的43.5倍
$7.0M
净利率更高
TCOM
高出46.4%
-18.6%
损益表 — Q2 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $7.0M | $304.6M |
| 净利润 | $-1.3M | $84.6M |
| 毛利率 | 8.9% | 78.8% |
| 营业利润率 | -20.5% | 16.5% |
| 净利率 | -18.6% | 27.8% |
| 营收同比 | — | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AHGTCOM
| Q4 25 | — | $304.6M | ||
| Q3 25 | $7.0M | — | ||
| Q2 24 | — | $242.7M | ||
| Q2 23 | — | $214.5M | ||
| Q4 22 | — | $100.7M | ||
| Q3 22 | — | $82.7M |
净利润AHGTCOM
| Q4 25 | — | $84.6M | ||
| Q3 25 | $-1.3M | — | ||
| Q2 24 | — | $73.8M | ||
| Q2 23 | — | $12.6M | ||
| Q4 22 | — | $41.5M | ||
| Q3 22 | — | $152.6M |
毛利率AHGTCOM
| Q4 25 | — | 78.8% | ||
| Q3 25 | 8.9% | — | ||
| Q2 24 | — | 81.8% | ||
| Q2 23 | — | 82.0% | ||
| Q4 22 | — | 76.0% | ||
| Q3 22 | — | 75.5% |
营业利润率AHGTCOM
| Q4 25 | — | 16.5% | ||
| Q3 25 | -20.5% | — | ||
| Q2 24 | — | 27.8% | ||
| Q2 23 | — | 26.4% | ||
| Q4 22 | — | — | ||
| Q3 22 | — | -4.2% |
净利率AHGTCOM
| Q4 25 | — | 27.8% | ||
| Q3 25 | -18.6% | — | ||
| Q2 24 | — | 30.4% | ||
| Q2 23 | — | 5.9% | ||
| Q4 22 | — | 41.2% | ||
| Q3 22 | — | 184.6% |
每股收益（稀释后）AHGTCOM
| Q4 25 | — | $0.12 | ||
| Q3 25 | — | — | ||
| Q2 24 | — | $0.11 | ||
| Q2 23 | — | $0.02 | ||
| Q4 22 | — | $0.06 | ||
| Q3 22 | — | $0.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.1M | $10.8B |
| 总债务越低越好 | — | $4.2B |
| 股东权益账面价值 | $198.3M | $23.8B |
| 总资产 | $212.0M | $36.9B |
| 负债/权益比越低杠杆越低 | — | 0.18× |
8季度趋势，按日历期对齐
现金及短期投资AHGTCOM
| Q4 25 | — | $10.8B | ||
| Q3 25 | $11.1M | — | ||
| Q2 24 | — | $12.4B | ||
| Q2 23 | — | $7.6B | ||
| Q4 22 | — | $6.2B | ||
| Q3 22 | — | $7.4B |
总债务AHGTCOM
| Q4 25 | — | $4.2B | ||
| Q3 25 | — | — | ||
| Q2 24 | — | $8.2B | ||
| Q2 23 | — | $7.2B | ||
| Q4 22 | — | $1.8B | ||
| Q3 22 | — | $7.4B |
股东权益AHGTCOM
| Q4 25 | — | $23.8B | ||
| Q3 25 | $198.3M | — | ||
| Q2 24 | — | $18.1B | ||
| Q2 23 | — | $16.3B | ||
| Q4 22 | — | $16.3B | ||
| Q3 22 | — | $15.2B |
总资产AHGTCOM
| Q4 25 | — | $36.9B | ||
| Q3 25 | $212.0M | — | ||
| Q2 24 | — | $34.2B | ||
| Q2 23 | — | $30.1B | ||
| Q4 22 | — | $27.8B | ||
| Q3 22 | — | $26.9B |
负债/权益比AHGTCOM
| Q4 25 | — | 0.18× | ||
| Q3 25 | — | — | ||
| Q2 24 | — | 0.45× | ||
| Q2 23 | — | 0.44× | ||
| Q4 22 | — | 0.11× | ||
| Q3 22 | — | 0.49× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AHGTCOM
| Q4 25 | — | — | ||
| Q3 25 | $1.2M | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q4 22 | — | $380.0M | ||
| Q3 22 | — | — |
自由现金流AHGTCOM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q4 22 | — | $308.0M | ||
| Q3 22 | — | — |
自由现金流率AHGTCOM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q4 22 | — | 305.7% | ||
| Q3 22 | — | — |
资本支出强度AHGTCOM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q4 22 | — | 71.5% | ||
| Q3 22 | — | — |
现金转化率AHGTCOM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q4 22 | — | 9.15× | ||
| Q3 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
